iVEAcare

About iVEAcare

iVEAcare is a medical device company focused on developing and commercializing next-generation neuromodulation technology platforms to treat patients with chronic diseases, addressing unmet clinical needs impacting large patient populations.

Products & Services

Neuromodulation Therapy:Innovative therapy designed to treat unmet clinical needs in chronic diseases using advanced neuromodulation technology.

Specialties

Neuromodulation Technology Bioelectronics Implantable Medical Devices

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 27500000 MR: - FA: 27.5 million FAN: 27500000	D: 2024-04-22 FD: 2024-04-22	4 investors

Series A Latest

2024-04-22

$27.5M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Todd Kerkow

Co-Founder, President, and CEO

D

Diane Burnside

VP Clinical Affairs

J

Jake Ludwig

Vice President, Research & Development

C

Cheryl Swanson

Vice President Quality and Regulatory Affairs

M

Mudit K. Jain

Founder and Chairman of the Board

L

Lynn Elliott

Founder and Board Member

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

iVEAcare Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised